Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Prostate. 2016 Jun 21;76(15):1399–1408. doi: 10.1002/pros.23224

Table 3. Characteristics* of Cases with Progression from No/Very Low or Low LUTS and Controls, Placebo Arm, PCPT.

Progression from no/very low LUTS** Progression from low LUTS***

Controls Cases P Controls Cases P
N 45 46 46 46
Age at end of study biopsy in years (mean) 69.4 69.6 **** 70.1 69.8 ****
White (%) 95.6 95.7 **** 95.7 95.7 ****
College education or higher (%) 44.4 47.8 0.7 50 58.7 0.4
BMI in kg/m2 (mean) 26.8 28.0 0.07 28.2 27.6 0.5
Waist circumference in cm (mean) 96.7 102.5 0.02 103.0 100.7 0.3
Moderate or higher physical activity (%) 26.8 28.0 0.07 28.2 27.6 0.5
Ever smoked cigarettes (%) 53.3 54.4 0.9 82.6 71.7 0.2
 Pack years among those who ever smoked (mean) 20.7 23.0 0.6 22.9 27.1 0.3
History of diabetes (%) 8.9 0 0.06 4.4 4.4 1.0
Aspirin use (%) 42.2 26.1 0.1 50.0 30.4 0.05
Serum PSA just prior to the end of study biopsy in ng/mL (mean) 1.7 1.8 0.7 1.8 2.0 0.5
Prostate cancer diagnosis on end of study biopsy (%) 20.0 21.7 0.8 23.9 19.6 0.6
Daily intake (mean)
 Energy in kcal 2,106 1,897 0.2 2,119 2,449 0.09
 Vegetables in servings, 5-A-Day Method 2.3 2.1 0.6 2.2 2.7 0.2
 Total fat in g 75.2 67.1 0.2 76.1 90.3 0.1
 Polyunsaturated fatty acids in g 16.0 13.4 0.09 15.8 18.7 0.1
 Total protein in g 90.5 80.0 0.1 88.6 104.4 0.07
 Red meat in servings 4.5 3.6 0.09 3.8 5.1 0.05
 Alcoholic beverages in number of drinks 1.0 0.7 0.4 0.7 1.0 0.3
IPSS (mean)
 Baseline 4.9 4.0 0.03 10.5 9.5 0.003
  Year 1 3.9 4.9 0.1 8.9 10.9 0.01
  Year 2 4.3 6.8 0.002 8.2 12.2 <0.0001
  Year 3 4.3 7.6 0.0001 9.4 11.9 0.005
  Year 4 4.2 8.2 <0.0001 8.7 13 <0.0001
  Year 5 5.1 8.6 <0.0001 8.5 13.3 <0.0001
  Year 6 3.9 9.5 <0.0001 8.6 15.1 <0.0001
  Year 7 2.9 12.2 <0.0001 7.1 16.8 <0.0001
 Mean change in IPSS from baseline to year 7 -2.0 8.3 <0.0001 -3.4 7.3 <0.0001
*

Baseline unless otherwise specified.

**

Controls had IPSS < 8 at baseline and baseline to year 7 slope < 25th percentile. Cases had IPSS < 8 at baseline and baseline to year 7 slope >75th percentile.

***

Controls had IPSS = 8-14 at baseline and baseline to year 7 slope < 25th percentile. Cases had IPSS = 8-14 at baseline and baseline to year 7 slope >75th percentile.

****

Frequency matched.